Matthew Yan
Stock Analyst at CLSA
(3.91)
# 1,846
Out of 5,053 analysts
45
Total ratings
61%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Matthew Yan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Buy | $136.90 → $144.80 | $66.70 | +117.09% | 6 | Aug 25, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $120.10 | $89.55 | +34.12% | 17 | Dec 8, 2025 | |
| HKG: 6160 BeOne Medicines AG | Reiterated: Buy | $264.40 → $288.00 | $210.20 | +37.01% | 10 | Nov 7, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $548.60 | $440.80 | +24.46% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Initiated Coverage: Buy | $268.30 | $167.80 | n/a | 1 | May 22, 2025 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $270 → $263 | $349.08 | n/a | 3 | Nov 13, 2024 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥6,800 → ¥7,000 | ¥2,602 | n/a | 4 | Oct 31, 2024 | |
| HKG: 0013 HUTCHMED (China) Limited | Reiterated: Buy | $40.53 | $21.52 | n/a | 1 | Aug 3, 2023 |
RemeGen Co., Ltd.
Aug 25, 2026
Reiterated: Buy
Price Target: $136.90 → $144.80
Current: $66.70
Upside: +117.09%
Innovent Biologics, Inc.
Dec 8, 2025
Reiterated: Buy
Price Target: $120.10
Current: $89.55
Upside: +34.12%
BeOne Medicines AG
Nov 7, 2025
Reiterated: Buy
Price Target: $264.40 → $288.00
Current: $210.20
Upside: +37.01%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 19, 2025
Reiterated: Buy
Price Target: $548.60
Current: $440.80
Upside: +24.46%
Duality Biotherapeutics, Inc.
May 22, 2025
Initiated Coverage: Buy
Price Target: $268.30
Current: $167.80
Upside: n/a
BeOne Medicines AG
Nov 13, 2024
Reiterated: Buy
Price Target: $270 → $263
Current: $349.08
Upside: n/a
Daiichi Sankyo Company, Limited
Oct 31, 2024
Reiterated: Buy
Price Target: ¥6,800 → ¥7,000
Current: ¥2,602
Upside: n/a
HUTCHMED (China) Limited
Aug 3, 2023
Reiterated: Buy
Price Target: $40.53
Current: $21.52
Upside: n/a